" /> Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 - CISMeF





Preferred Label : Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931;

NCIt synonyms : Monovalent HPV18 Ad26-vectored Vaccine JNJ-63682931; Adenovirus Serotype 26-Human Papillomavirus 18 JNJ-63682931; Ad26.HPV18 JNJ-63682931; Ad26-expressing HPV18 Vaccine JNJ-63682931;

NCIt definition : A prime cancer vaccine comprised of a genetically engineered, replication-deficient adenovirus serotype 26 (Ad26) encoding the oncogenic human papillomavirus 18 (HPV18), with potential immunostimulating and antineoplastic activities. Upon intramuscular administration of Ad26-expressing HPV18 vaccine JNJ-63682931, the adenovirus infects and expresses HPV18. The expressed proteins stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV18 antigens, thereby inducing tumor cell lysis. HPV18 infection plays a key role in the development of a variety of cancers.;

Molecule name : JNJ-63682931; JNJ 63682931;

NCI Metathesaurus CUI : CL972333;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.